ArticleInternational journal of hematology2019

Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients.

Szilvia Lovas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.